Researchers from IDIS and CiMUS of USC lead the first trial of an oral drug for the treatment of COVID patients, aimed at stopping the multiplication of the virus

SIGMA4COVID is the name of the trial that is carried out in various Atención Primaria de Galicia and Cataluña and is promoted, among others, by Instituto de Investigación Sanitaria de Santiago de Compostela(IDIS), the Hospital del Mar in Barcelona and the Pharmaceutical ESTEVE
It is approved by the Spanish Medicines Agency, AEMPS, and is in phase II of development.

More Info